nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—SLC22A1—hematologic cancer	0.157	0.503	CbGaD
Estropipate—ESR1—hematologic cancer	0.107	0.344	CbGaD
Estropipate—Exemestane—Prednisone—hematologic cancer	0.0607	0.506	CrCrCtD
Estropipate—Exemestane—Prednisolone—hematologic cancer	0.0592	0.494	CrCrCtD
Estropipate—ALB—hematologic cancer	0.0478	0.153	CbGaD
Estropipate—SLC22A1—Cytarabine—hematologic cancer	0.0205	0.062	CbGbCtD
Estropipate—CYP1A2—Anagrelide—hematologic cancer	0.02	0.0606	CbGbCtD
Estropipate—SLC22A1—Cladribine—hematologic cancer	0.0193	0.0586	CbGbCtD
Estropipate—SLC22A1—Imatinib—hematologic cancer	0.0178	0.0539	CbGbCtD
Estropipate—CYP2C9—Bexarotene—hematologic cancer	0.0125	0.0379	CbGbCtD
Estropipate—CYP1A2—Carmustine—hematologic cancer	0.0105	0.0319	CbGbCtD
Estropipate—ALB—Imatinib—hematologic cancer	0.0104	0.0316	CbGbCtD
Estropipate—CYP2C9—Idarubicin—hematologic cancer	0.0104	0.0314	CbGbCtD
Estropipate—ESR2—ovarian follicle—hematologic cancer	0.0094	0.295	CbGeAlD
Estropipate—CYP1A2—Methoxsalen—hematologic cancer	0.00894	0.0271	CbGbCtD
Estropipate—CYP1A2—Bortezomib—hematologic cancer	0.00851	0.0258	CbGbCtD
Estropipate—CYP1A2—Daunorubicin—hematologic cancer	0.00814	0.0246	CbGbCtD
Estropipate—CYP1A2—Alitretinoin—hematologic cancer	0.00797	0.0241	CbGbCtD
Estropipate—CYP2C9—Bortezomib—hematologic cancer	0.00766	0.0232	CbGbCtD
Estropipate—CYP1A2—Thalidomide—hematologic cancer	0.00741	0.0224	CbGbCtD
Estropipate—CYP3A4—Bexarotene—hematologic cancer	0.00727	0.022	CbGbCtD
Estropipate—ALB—Prednisone—hematologic cancer	0.00686	0.0208	CbGbCtD
Estropipate—CYP3A4—Lomustine—hematologic cancer	0.00676	0.0205	CbGbCtD
Estropipate—CYP3A4—Busulfan—hematologic cancer	0.00676	0.0205	CbGbCtD
Estropipate—CYP2C9—Thalidomide—hematologic cancer	0.00668	0.0202	CbGbCtD
Estropipate—ALB—Irinotecan—hematologic cancer	0.00651	0.0197	CbGbCtD
Estropipate—ESR1—ovarian follicle—hematologic cancer	0.00644	0.202	CbGeAlD
Estropipate—CYP1A2—Dacarbazine—hematologic cancer	0.00637	0.0193	CbGbCtD
Estropipate—CYP2C9—Teniposide—hematologic cancer	0.00637	0.0193	CbGbCtD
Estropipate—CYP1A2—Imatinib—hematologic cancer	0.00623	0.0189	CbGbCtD
Estropipate—CYP3A4—Thiotepa—hematologic cancer	0.00602	0.0182	CbGbCtD
Estropipate—CYP2C9—Ifosfamide—hematologic cancer	0.00588	0.0178	CbGbCtD
Estropipate—CYP2C9—Imatinib—hematologic cancer	0.00562	0.017	CbGbCtD
Estropipate—CYP2C9—Nilotinib—hematologic cancer	0.0051	0.0155	CbGbCtD
Estropipate—CYP1A2—Dasatinib—hematologic cancer	0.00501	0.0152	CbGbCtD
Estropipate—CYP3A4—Methoxsalen—hematologic cancer	0.00469	0.0142	CbGbCtD
Estropipate—CYP3A4—Bortezomib—hematologic cancer	0.00446	0.0135	CbGbCtD
Estropipate—CYP3A4—Daunorubicin—hematologic cancer	0.00426	0.0129	CbGbCtD
Estropipate—CYP3A4—Cytarabine—hematologic cancer	0.00376	0.0114	CbGbCtD
Estropipate—CYP3A4—Teniposide—hematologic cancer	0.0037	0.0112	CbGbCtD
Estropipate—ALB—Methotrexate—hematologic cancer	0.00344	0.0104	CbGbCtD
Estropipate—CYP3A4—Ifosfamide—hematologic cancer	0.00342	0.0104	CbGbCtD
Estropipate—CYP3A4—Imatinib—hematologic cancer	0.00326	0.00989	CbGbCtD
Estropipate—CYP1A2—Etoposide—hematologic cancer	0.00312	0.00944	CbGbCtD
Estropipate—CYP3A4—Ruxolitinib—hematologic cancer	0.00307	0.00931	CbGbCtD
Estropipate—CYP3A4—Nilotinib—hematologic cancer	0.00297	0.00899	CbGbCtD
Estropipate—CYP3A4—Vinorelbine—hematologic cancer	0.00294	0.00891	CbGbCtD
Estropipate—CYP2C9—Cisplatin—hematologic cancer	0.00286	0.00866	CbGbCtD
Estropipate—CYP3A4—Triamcinolone—hematologic cancer	0.00269	0.00815	CbGbCtD
Estropipate—CYP3A4—Dasatinib—hematologic cancer	0.00262	0.00794	CbGbCtD
Estropipate—CYP3A4—Mitoxantrone—hematologic cancer	0.00259	0.00785	CbGbCtD
Estropipate—CYP2C9—Dexamethasone—hematologic cancer	0.00231	0.007	CbGbCtD
Estropipate—CYP3A4—Betamethasone—hematologic cancer	0.00231	0.00699	CbGbCtD
Estropipate—CYP3A4—Prednisolone—hematologic cancer	0.00228	0.0069	CbGbCtD
Estropipate—CYP3A4—Prednisone—hematologic cancer	0.00215	0.00652	CbGbCtD
Estropipate—CYP3A4—Irinotecan—hematologic cancer	0.00204	0.00618	CbGbCtD
Estropipate—CYP3A4—Vinblastine—hematologic cancer	0.00181	0.00549	CbGbCtD
Estropipate—CYP3A4—Vincristine—hematologic cancer	0.00178	0.0054	CbGbCtD
Estropipate—CYP3A4—Etoposide—hematologic cancer	0.00163	0.00495	CbGbCtD
Estropipate—CYP3A4—Dexamethasone—hematologic cancer	0.00134	0.00407	CbGbCtD
Estropipate—ESR2—hematopoietic system—hematologic cancer	0.00114	0.0356	CbGeAlD
Estropipate—CYP3A4—Doxorubicin—hematologic cancer	0.00111	0.00337	CbGbCtD
Estropipate—SHBG—hematopoietic system—hematologic cancer	0.0011	0.0346	CbGeAlD
Estropipate—ESR2—gonad—hematologic cancer	0.000863	0.0271	CbGeAlD
Estropipate—SHBG—gonad—hematologic cancer	0.000839	0.0263	CbGeAlD
Estropipate—ESR1—hematopoietic system—hematologic cancer	0.000778	0.0244	CbGeAlD
Estropipate—ESR2—blood—hematologic cancer	0.000752	0.0236	CbGeAlD
Estropipate—SHBG—blood—hematologic cancer	0.000731	0.0229	CbGeAlD
Estropipate—SHBG—bone marrow—hematologic cancer	0.000707	0.0222	CbGeAlD
Estropipate—ESR2—lung—hematologic cancer	0.000659	0.0207	CbGeAlD
Estropipate—SLC22A1—blood—hematologic cancer	0.000631	0.0198	CbGeAlD
Estropipate—ESR2—testis—hematologic cancer	0.000622	0.0195	CbGeAlD
Estropipate—SHBG—testis—hematologic cancer	0.000605	0.019	CbGeAlD
Estropipate—CYP1A2—hematopoietic system—hematologic cancer	0.000599	0.0188	CbGeAlD
Estropipate—ESR1—gonad—hematologic cancer	0.000591	0.0185	CbGeAlD
Estropipate—CYP2C9—hematopoietic system—hematologic cancer	0.000569	0.0178	CbGeAlD
Estropipate—ESR1—blood—hematologic cancer	0.000515	0.0162	CbGeAlD
Estropipate—ALB—testis—hematologic cancer	0.000499	0.0157	CbGeAlD
Estropipate—ESR1—lung—hematologic cancer	0.000452	0.0142	CbGeAlD
Estropipate—ESR2—lymph node—hematologic cancer	0.000451	0.0141	CbGeAlD
Estropipate—CYP3A4—hematopoietic system—hematologic cancer	0.000434	0.0136	CbGeAlD
Estropipate—ESR1—testis—hematologic cancer	0.000426	0.0134	CbGeAlD
Estropipate—CYP1A2—blood—hematologic cancer	0.000397	0.0125	CbGeAlD
Estropipate—CYP2C9—blood—hematologic cancer	0.000377	0.0118	CbGeAlD
Estropipate—ALB—lymph node—hematologic cancer	0.000362	0.0114	CbGeAlD
Estropipate—CYP1A2—lung—hematologic cancer	0.000348	0.0109	CbGeAlD
Estropipate—ESR1—lymph node—hematologic cancer	0.000309	0.00968	CbGeAlD
Estropipate—Quinestrol—ESR1—hematologic cancer	0.000301	0.122	CrCbGaD
Estropipate—CYP3A4—blood—hematologic cancer	0.000287	0.00901	CbGeAlD
Estropipate—Mestranol—ESR1—hematologic cancer	0.000228	0.0922	CrCbGaD
Estropipate—Conjugated Estrogens—ABCC3—hematologic cancer	0.0002	0.0807	CrCbGaD
Estropipate—Estriol—ESR1—hematologic cancer	0.000199	0.0805	CrCbGaD
Estropipate—Estramustine—ESR1—hematologic cancer	0.000185	0.0748	CrCbGaD
Estropipate—Estradiol—UGT1A1—hematologic cancer	0.00013	0.0527	CrCbGaD
Estropipate—Ethinyl Estradiol—ESR1—hematologic cancer	0.000109	0.044	CrCbGaD
Estropipate—Estradiol—SLC22A1—hematologic cancer	0.000105	0.0424	CrCbGaD
Estropipate—Conjugated Estrogens—ABCG2—hematologic cancer	9.7e-05	0.0392	CrCbGaD
Estropipate—Estrone—ABCG2—hematologic cancer	9.67e-05	0.0391	CrCbGaD
Estropipate—Conjugated Estrogens—ESR1—hematologic cancer	9.5e-05	0.0384	CrCbGaD
Estropipate—Estrone—ESR1—hematologic cancer	9.47e-05	0.0383	CrCbGaD
Estropipate—Estradiol—AR—hematologic cancer	9.32e-05	0.0377	CrCbGaD
Estropipate—Estriol—ABCB1—hematologic cancer	8.46e-05	0.0342	CrCbGaD
Estropipate—Estramustine—ABCB1—hematologic cancer	7.86e-05	0.0318	CrCbGaD
Estropipate—Estradiol—ABCG2—hematologic cancer	7.33e-05	0.0296	CrCbGaD
Estropipate—Estradiol—ESR1—hematologic cancer	7.18e-05	0.029	CrCbGaD
Estropipate—Ethinyl Estradiol—ABCB1—hematologic cancer	4.62e-05	0.0187	CrCbGaD
Estropipate—Estrone—ALB—hematologic cancer	4.22e-05	0.0171	CrCbGaD
Estropipate—Conjugated Estrogens—ABCB1—hematologic cancer	4.04e-05	0.0163	CrCbGaD
Estropipate—Estrone—ABCB1—hematologic cancer	4.02e-05	0.0163	CrCbGaD
Estropipate—Estradiol—ALB—hematologic cancer	3.2e-05	0.0129	CrCbGaD
Estropipate—Estradiol—ABCB1—hematologic cancer	3.05e-05	0.0123	CrCbGaD
Estropipate—Nausea—Ifosfamide—hematologic cancer	1.76e-05	0.000119	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	1.75e-05	0.000119	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Betamethasone—hematologic cancer	1.75e-05	0.000119	CcSEcCtD
Estropipate—Arthralgia—Prednisone—hematologic cancer	1.75e-05	0.000118	CcSEcCtD
Estropipate—Myalgia—Prednisone—hematologic cancer	1.75e-05	0.000118	CcSEcCtD
Estropipate—Diarrhoea—Cisplatin—hematologic cancer	1.75e-05	0.000118	CcSEcCtD
Estropipate—Erythema multiforme—Epirubicin—hematologic cancer	1.74e-05	0.000118	CcSEcCtD
Estropipate—Anxiety—Prednisone—hematologic cancer	1.74e-05	0.000118	CcSEcCtD
Estropipate—Alopecia—Methotrexate—hematologic cancer	1.74e-05	0.000118	CcSEcCtD
Estropipate—Vomiting—Gemcitabine—hematologic cancer	1.74e-05	0.000118	CcSEcCtD
Estropipate—Insomnia—Dexamethasone—hematologic cancer	1.74e-05	0.000118	CcSEcCtD
Estropipate—Insomnia—Betamethasone—hematologic cancer	1.74e-05	0.000118	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	1.74e-05	0.000118	CcSEcCtD
Estropipate—Paraesthesia—Betamethasone—hematologic cancer	1.73e-05	0.000117	CcSEcCtD
Estropipate—Paraesthesia—Dexamethasone—hematologic cancer	1.73e-05	0.000117	CcSEcCtD
Estropipate—Mental disorder—Methotrexate—hematologic cancer	1.73e-05	0.000117	CcSEcCtD
Estropipate—Rash—Gemcitabine—hematologic cancer	1.73e-05	0.000117	CcSEcCtD
Estropipate—Dermatitis—Gemcitabine—hematologic cancer	1.72e-05	0.000117	CcSEcCtD
Estropipate—Eye disorder—Epirubicin—hematologic cancer	1.72e-05	0.000117	CcSEcCtD
Estropipate—Hypersensitivity—Etoposide—hematologic cancer	1.72e-05	0.000117	CcSEcCtD
Estropipate—Erythema—Methotrexate—hematologic cancer	1.72e-05	0.000116	CcSEcCtD
Estropipate—Malnutrition—Methotrexate—hematologic cancer	1.72e-05	0.000116	CcSEcCtD
Estropipate—Headache—Gemcitabine—hematologic cancer	1.71e-05	0.000116	CcSEcCtD
Estropipate—Nausea—Vincristine—hematologic cancer	1.71e-05	0.000116	CcSEcCtD
Estropipate—Cardiac disorder—Epirubicin—hematologic cancer	1.71e-05	0.000116	CcSEcCtD
Estropipate—Rhinitis—Doxorubicin—hematologic cancer	1.71e-05	0.000116	CcSEcCtD
Estropipate—Hypersensitivity—Prednisolone—hematologic cancer	1.7e-05	0.000115	CcSEcCtD
Estropipate—Pharyngitis—Doxorubicin—hematologic cancer	1.69e-05	0.000115	CcSEcCtD
Estropipate—Dyspepsia—Betamethasone—hematologic cancer	1.69e-05	0.000115	CcSEcCtD
Estropipate—Dyspepsia—Dexamethasone—hematologic cancer	1.69e-05	0.000115	CcSEcCtD
Estropipate—Urticaria—Triamcinolone—hematologic cancer	1.68e-05	0.000114	CcSEcCtD
Estropipate—Oedema peripheral—Doxorubicin—hematologic cancer	1.68e-05	0.000114	CcSEcCtD
Estropipate—Asthenia—Etoposide—hematologic cancer	1.68e-05	0.000114	CcSEcCtD
Estropipate—Body temperature increased—Triamcinolone—hematologic cancer	1.68e-05	0.000113	CcSEcCtD
Estropipate—Anaphylactic shock—Prednisone—hematologic cancer	1.67e-05	0.000113	CcSEcCtD
Estropipate—Oedema—Prednisone—hematologic cancer	1.67e-05	0.000113	CcSEcCtD
Estropipate—Angiopathy—Epirubicin—hematologic cancer	1.67e-05	0.000113	CcSEcCtD
Estropipate—Nausea—Irinotecan—hematologic cancer	1.67e-05	0.000113	CcSEcCtD
Estropipate—Nausea—Mitoxantrone—hematologic cancer	1.67e-05	0.000113	CcSEcCtD
Estropipate—Immune system disorder—Epirubicin—hematologic cancer	1.67e-05	0.000113	CcSEcCtD
Estropipate—Infection—Prednisone—hematologic cancer	1.66e-05	0.000113	CcSEcCtD
Estropipate—Mediastinal disorder—Epirubicin—hematologic cancer	1.66e-05	0.000113	CcSEcCtD
Estropipate—Gastrointestinal disorder—Dexamethasone—hematologic cancer	1.66e-05	0.000112	CcSEcCtD
Estropipate—Gastrointestinal disorder—Betamethasone—hematologic cancer	1.66e-05	0.000112	CcSEcCtD
Estropipate—Back pain—Methotrexate—hematologic cancer	1.66e-05	0.000112	CcSEcCtD
Estropipate—Fatigue—Dexamethasone—hematologic cancer	1.66e-05	0.000112	CcSEcCtD
Estropipate—Fatigue—Betamethasone—hematologic cancer	1.66e-05	0.000112	CcSEcCtD
Estropipate—Pruritus—Etoposide—hematologic cancer	1.65e-05	0.000112	CcSEcCtD
Estropipate—Pain—Dexamethasone—hematologic cancer	1.64e-05	0.000111	CcSEcCtD
Estropipate—Pain—Betamethasone—hematologic cancer	1.64e-05	0.000111	CcSEcCtD
Estropipate—Visual impairment—Doxorubicin—hematologic cancer	1.64e-05	0.000111	CcSEcCtD
Estropipate—Nervous system disorder—Prednisone—hematologic cancer	1.64e-05	0.000111	CcSEcCtD
Estropipate—Alopecia—Epirubicin—hematologic cancer	1.63e-05	0.00011	CcSEcCtD
Estropipate—Skin disorder—Prednisone—hematologic cancer	1.63e-05	0.00011	CcSEcCtD
Estropipate—Nausea—Gemcitabine—hematologic cancer	1.63e-05	0.00011	CcSEcCtD
Estropipate—Vomiting—Cisplatin—hematologic cancer	1.62e-05	0.00011	CcSEcCtD
Estropipate—Mental disorder—Epirubicin—hematologic cancer	1.62e-05	0.000109	CcSEcCtD
Estropipate—Erythema multiforme—Doxorubicin—hematologic cancer	1.61e-05	0.000109	CcSEcCtD
Estropipate—Rash—Cisplatin—hematologic cancer	1.61e-05	0.000109	CcSEcCtD
Estropipate—Dermatitis—Cisplatin—hematologic cancer	1.61e-05	0.000109	CcSEcCtD
Estropipate—Malnutrition—Epirubicin—hematologic cancer	1.61e-05	0.000109	CcSEcCtD
Estropipate—Erythema—Epirubicin—hematologic cancer	1.61e-05	0.000109	CcSEcCtD
Estropipate—Diarrhoea—Etoposide—hematologic cancer	1.6e-05	0.000108	CcSEcCtD
Estropipate—Eye disorder—Doxorubicin—hematologic cancer	1.59e-05	0.000108	CcSEcCtD
Estropipate—Cardiac disorder—Doxorubicin—hematologic cancer	1.58e-05	0.000107	CcSEcCtD
Estropipate—Flatulence—Epirubicin—hematologic cancer	1.58e-05	0.000107	CcSEcCtD
Estropipate—Tension—Epirubicin—hematologic cancer	1.58e-05	0.000107	CcSEcCtD
Estropipate—Gastrointestinal pain—Betamethasone—hematologic cancer	1.57e-05	0.000107	CcSEcCtD
Estropipate—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.57e-05	0.000107	CcSEcCtD
Estropipate—Hypersensitivity—Triamcinolone—hematologic cancer	1.56e-05	0.000106	CcSEcCtD
Estropipate—Nervousness—Epirubicin—hematologic cancer	1.56e-05	0.000106	CcSEcCtD
Estropipate—Back pain—Epirubicin—hematologic cancer	1.55e-05	0.000105	CcSEcCtD
Estropipate—Angiopathy—Doxorubicin—hematologic cancer	1.55e-05	0.000105	CcSEcCtD
Estropipate—Dizziness—Etoposide—hematologic cancer	1.55e-05	0.000105	CcSEcCtD
Estropipate—Muscle spasms—Epirubicin—hematologic cancer	1.54e-05	0.000104	CcSEcCtD
Estropipate—Immune system disorder—Doxorubicin—hematologic cancer	1.54e-05	0.000104	CcSEcCtD
Estropipate—Vertigo—Methotrexate—hematologic cancer	1.54e-05	0.000104	CcSEcCtD
Estropipate—Mediastinal disorder—Doxorubicin—hematologic cancer	1.54e-05	0.000104	CcSEcCtD
Estropipate—Urticaria—Betamethasone—hematologic cancer	1.53e-05	0.000103	CcSEcCtD
Estropipate—Urticaria—Dexamethasone—hematologic cancer	1.53e-05	0.000103	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.53e-05	0.000103	CcSEcCtD
Estropipate—Dizziness—Prednisolone—hematologic cancer	1.52e-05	0.000103	CcSEcCtD
Estropipate—Asthenia—Triamcinolone—hematologic cancer	1.52e-05	0.000103	CcSEcCtD
Estropipate—Abdominal pain—Dexamethasone—hematologic cancer	1.52e-05	0.000103	CcSEcCtD
Estropipate—Abdominal pain—Betamethasone—hematologic cancer	1.52e-05	0.000103	CcSEcCtD
Estropipate—Body temperature increased—Dexamethasone—hematologic cancer	1.52e-05	0.000103	CcSEcCtD
Estropipate—Body temperature increased—Betamethasone—hematologic cancer	1.52e-05	0.000103	CcSEcCtD
Estropipate—Nausea—Cisplatin—hematologic cancer	1.52e-05	0.000103	CcSEcCtD
Estropipate—Insomnia—Prednisone—hematologic cancer	1.51e-05	0.000103	CcSEcCtD
Estropipate—Alopecia—Doxorubicin—hematologic cancer	1.51e-05	0.000102	CcSEcCtD
Estropipate—Paraesthesia—Prednisone—hematologic cancer	1.5e-05	0.000102	CcSEcCtD
Estropipate—Pruritus—Triamcinolone—hematologic cancer	1.5e-05	0.000102	CcSEcCtD
Estropipate—Cough—Methotrexate—hematologic cancer	1.5e-05	0.000101	CcSEcCtD
Estropipate—Mental disorder—Doxorubicin—hematologic cancer	1.49e-05	0.000101	CcSEcCtD
Estropipate—Vomiting—Etoposide—hematologic cancer	1.49e-05	0.000101	CcSEcCtD
Estropipate—Erythema—Doxorubicin—hematologic cancer	1.49e-05	0.000101	CcSEcCtD
Estropipate—Malnutrition—Doxorubicin—hematologic cancer	1.49e-05	0.000101	CcSEcCtD
Estropipate—Dyspepsia—Prednisone—hematologic cancer	1.47e-05	9.98e-05	CcSEcCtD
Estropipate—Rash—Etoposide—hematologic cancer	1.47e-05	9.98e-05	CcSEcCtD
Estropipate—Dermatitis—Etoposide—hematologic cancer	1.47e-05	9.97e-05	CcSEcCtD
Estropipate—Headache—Etoposide—hematologic cancer	1.46e-05	9.91e-05	CcSEcCtD
Estropipate—Flatulence—Doxorubicin—hematologic cancer	1.46e-05	9.91e-05	CcSEcCtD
Estropipate—Arthralgia—Methotrexate—hematologic cancer	1.46e-05	9.89e-05	CcSEcCtD
Estropipate—Myalgia—Methotrexate—hematologic cancer	1.46e-05	9.89e-05	CcSEcCtD
Estropipate—Tension—Doxorubicin—hematologic cancer	1.46e-05	9.87e-05	CcSEcCtD
Estropipate—Rash—Prednisolone—hematologic cancer	1.45e-05	9.84e-05	CcSEcCtD
Estropipate—Dermatitis—Prednisolone—hematologic cancer	1.45e-05	9.83e-05	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.45e-05	9.82e-05	CcSEcCtD
Estropipate—Fatigue—Prednisone—hematologic cancer	1.44e-05	9.78e-05	CcSEcCtD
Estropipate—Headache—Prednisolone—hematologic cancer	1.44e-05	9.78e-05	CcSEcCtD
Estropipate—Nervousness—Doxorubicin—hematologic cancer	1.44e-05	9.77e-05	CcSEcCtD
Estropipate—Vertigo—Epirubicin—hematologic cancer	1.44e-05	9.77e-05	CcSEcCtD
Estropipate—Back pain—Doxorubicin—hematologic cancer	1.44e-05	9.73e-05	CcSEcCtD
Estropipate—Constipation—Prednisone—hematologic cancer	1.43e-05	9.7e-05	CcSEcCtD
Estropipate—Muscle spasms—Doxorubicin—hematologic cancer	1.43e-05	9.67e-05	CcSEcCtD
Estropipate—Palpitations—Epirubicin—hematologic cancer	1.42e-05	9.61e-05	CcSEcCtD
Estropipate—Dizziness—Triamcinolone—hematologic cancer	1.4e-05	9.49e-05	CcSEcCtD
Estropipate—Cough—Epirubicin—hematologic cancer	1.4e-05	9.48e-05	CcSEcCtD
Estropipate—Anaphylactic shock—Methotrexate—hematologic cancer	1.4e-05	9.48e-05	CcSEcCtD
Estropipate—Infection—Methotrexate—hematologic cancer	1.39e-05	9.42e-05	CcSEcCtD
Estropipate—Nausea—Etoposide—hematologic cancer	1.39e-05	9.4e-05	CcSEcCtD
Estropipate—Asthenia—Betamethasone—hematologic cancer	1.38e-05	9.34e-05	CcSEcCtD
Estropipate—Asthenia—Dexamethasone—hematologic cancer	1.38e-05	9.34e-05	CcSEcCtD
Estropipate—Nervous system disorder—Methotrexate—hematologic cancer	1.37e-05	9.3e-05	CcSEcCtD
Estropipate—Gastrointestinal pain—Prednisone—hematologic cancer	1.37e-05	9.27e-05	CcSEcCtD
Estropipate—Nausea—Prednisolone—hematologic cancer	1.37e-05	9.27e-05	CcSEcCtD
Estropipate—Arthralgia—Epirubicin—hematologic cancer	1.37e-05	9.25e-05	CcSEcCtD
Estropipate—Myalgia—Epirubicin—hematologic cancer	1.37e-05	9.25e-05	CcSEcCtD
Estropipate—Anxiety—Epirubicin—hematologic cancer	1.36e-05	9.22e-05	CcSEcCtD
Estropipate—Pruritus—Dexamethasone—hematologic cancer	1.36e-05	9.21e-05	CcSEcCtD
Estropipate—Pruritus—Betamethasone—hematologic cancer	1.36e-05	9.21e-05	CcSEcCtD
Estropipate—Skin disorder—Methotrexate—hematologic cancer	1.36e-05	9.21e-05	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.36e-05	9.19e-05	CcSEcCtD
Estropipate—Vomiting—Triamcinolone—hematologic cancer	1.35e-05	9.13e-05	CcSEcCtD
Estropipate—Rash—Triamcinolone—hematologic cancer	1.34e-05	9.05e-05	CcSEcCtD
Estropipate—Dermatitis—Triamcinolone—hematologic cancer	1.34e-05	9.04e-05	CcSEcCtD
Estropipate—Vertigo—Doxorubicin—hematologic cancer	1.33e-05	9.04e-05	CcSEcCtD
Estropipate—Urticaria—Prednisone—hematologic cancer	1.33e-05	9.01e-05	CcSEcCtD
Estropipate—Headache—Triamcinolone—hematologic cancer	1.33e-05	8.99e-05	CcSEcCtD
Estropipate—Abdominal pain—Prednisone—hematologic cancer	1.32e-05	8.97e-05	CcSEcCtD
Estropipate—Body temperature increased—Prednisone—hematologic cancer	1.32e-05	8.97e-05	CcSEcCtD
Estropipate—Diarrhoea—Dexamethasone—hematologic cancer	1.32e-05	8.91e-05	CcSEcCtD
Estropipate—Diarrhoea—Betamethasone—hematologic cancer	1.32e-05	8.91e-05	CcSEcCtD
Estropipate—Palpitations—Doxorubicin—hematologic cancer	1.31e-05	8.89e-05	CcSEcCtD
Estropipate—Anaphylactic shock—Epirubicin—hematologic cancer	1.31e-05	8.87e-05	CcSEcCtD
Estropipate—Oedema—Epirubicin—hematologic cancer	1.31e-05	8.87e-05	CcSEcCtD
Estropipate—Infection—Epirubicin—hematologic cancer	1.3e-05	8.81e-05	CcSEcCtD
Estropipate—Cough—Doxorubicin—hematologic cancer	1.3e-05	8.78e-05	CcSEcCtD
Estropipate—Nervous system disorder—Epirubicin—hematologic cancer	1.28e-05	8.7e-05	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.28e-05	8.64e-05	CcSEcCtD
Estropipate—Skin disorder—Epirubicin—hematologic cancer	1.27e-05	8.62e-05	CcSEcCtD
Estropipate—Dizziness—Dexamethasone—hematologic cancer	1.27e-05	8.61e-05	CcSEcCtD
Estropipate—Dizziness—Betamethasone—hematologic cancer	1.27e-05	8.61e-05	CcSEcCtD
Estropipate—Insomnia—Methotrexate—hematologic cancer	1.27e-05	8.57e-05	CcSEcCtD
Estropipate—Arthralgia—Doxorubicin—hematologic cancer	1.26e-05	8.56e-05	CcSEcCtD
Estropipate—Myalgia—Doxorubicin—hematologic cancer	1.26e-05	8.56e-05	CcSEcCtD
Estropipate—Anxiety—Doxorubicin—hematologic cancer	1.26e-05	8.53e-05	CcSEcCtD
Estropipate—Nausea—Triamcinolone—hematologic cancer	1.26e-05	8.53e-05	CcSEcCtD
Estropipate—Paraesthesia—Methotrexate—hematologic cancer	1.26e-05	8.51e-05	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.26e-05	8.5e-05	CcSEcCtD
Estropipate—Somnolence—Methotrexate—hematologic cancer	1.24e-05	8.43e-05	CcSEcCtD
Estropipate—Hypersensitivity—Prednisone—hematologic cancer	1.23e-05	8.36e-05	CcSEcCtD
Estropipate—Dyspepsia—Methotrexate—hematologic cancer	1.23e-05	8.34e-05	CcSEcCtD
Estropipate—Vomiting—Dexamethasone—hematologic cancer	1.22e-05	8.28e-05	CcSEcCtD
Estropipate—Vomiting—Betamethasone—hematologic cancer	1.22e-05	8.28e-05	CcSEcCtD
Estropipate—Rash—Dexamethasone—hematologic cancer	1.21e-05	8.21e-05	CcSEcCtD
Estropipate—Rash—Betamethasone—hematologic cancer	1.21e-05	8.21e-05	CcSEcCtD
Estropipate—Oedema—Doxorubicin—hematologic cancer	1.21e-05	8.21e-05	CcSEcCtD
Estropipate—Anaphylactic shock—Doxorubicin—hematologic cancer	1.21e-05	8.21e-05	CcSEcCtD
Estropipate—Dermatitis—Betamethasone—hematologic cancer	1.21e-05	8.2e-05	CcSEcCtD
Estropipate—Dermatitis—Dexamethasone—hematologic cancer	1.21e-05	8.2e-05	CcSEcCtD
Estropipate—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.21e-05	8.18e-05	CcSEcCtD
Estropipate—Fatigue—Methotrexate—hematologic cancer	1.21e-05	8.17e-05	CcSEcCtD
Estropipate—Headache—Dexamethasone—hematologic cancer	1.2e-05	8.16e-05	CcSEcCtD
Estropipate—Headache—Betamethasone—hematologic cancer	1.2e-05	8.16e-05	CcSEcCtD
Estropipate—Infection—Doxorubicin—hematologic cancer	1.2e-05	8.15e-05	CcSEcCtD
Estropipate—Asthenia—Prednisone—hematologic cancer	1.2e-05	8.14e-05	CcSEcCtD
Estropipate—Pain—Methotrexate—hematologic cancer	1.2e-05	8.11e-05	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.19e-05	8.08e-05	CcSEcCtD
Estropipate—Nervous system disorder—Doxorubicin—hematologic cancer	1.19e-05	8.05e-05	CcSEcCtD
Estropipate—Pruritus—Prednisone—hematologic cancer	1.19e-05	8.02e-05	CcSEcCtD
Estropipate—Insomnia—Epirubicin—hematologic cancer	1.18e-05	8.02e-05	CcSEcCtD
Estropipate—Skin disorder—Doxorubicin—hematologic cancer	1.18e-05	7.97e-05	CcSEcCtD
Estropipate—Paraesthesia—Epirubicin—hematologic cancer	1.18e-05	7.97e-05	CcSEcCtD
Estropipate—Somnolence—Epirubicin—hematologic cancer	1.16e-05	7.89e-05	CcSEcCtD
Estropipate—Dyspepsia—Epirubicin—hematologic cancer	1.15e-05	7.81e-05	CcSEcCtD
Estropipate—Diarrhoea—Prednisone—hematologic cancer	1.15e-05	7.76e-05	CcSEcCtD
Estropipate—Gastrointestinal pain—Methotrexate—hematologic cancer	1.14e-05	7.75e-05	CcSEcCtD
Estropipate—Nausea—Dexamethasone—hematologic cancer	1.14e-05	7.74e-05	CcSEcCtD
Estropipate—Nausea—Betamethasone—hematologic cancer	1.14e-05	7.74e-05	CcSEcCtD
Estropipate—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.13e-05	7.66e-05	CcSEcCtD
Estropipate—Fatigue—Epirubicin—hematologic cancer	1.13e-05	7.65e-05	CcSEcCtD
Estropipate—Pain—Epirubicin—hematologic cancer	1.12e-05	7.59e-05	CcSEcCtD
Estropipate—Constipation—Epirubicin—hematologic cancer	1.12e-05	7.59e-05	CcSEcCtD
Estropipate—Urticaria—Methotrexate—hematologic cancer	1.11e-05	7.53e-05	CcSEcCtD
Estropipate—Dizziness—Prednisone—hematologic cancer	1.11e-05	7.5e-05	CcSEcCtD
Estropipate—Abdominal pain—Methotrexate—hematologic cancer	1.11e-05	7.49e-05	CcSEcCtD
Estropipate—Body temperature increased—Methotrexate—hematologic cancer	1.11e-05	7.49e-05	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.1e-05	7.48e-05	CcSEcCtD
Estropipate—Insomnia—Doxorubicin—hematologic cancer	1.1e-05	7.42e-05	CcSEcCtD
Estropipate—Paraesthesia—Doxorubicin—hematologic cancer	1.09e-05	7.37e-05	CcSEcCtD
Estropipate—Somnolence—Doxorubicin—hematologic cancer	1.08e-05	7.3e-05	CcSEcCtD
Estropipate—Gastrointestinal pain—Epirubicin—hematologic cancer	1.07e-05	7.25e-05	CcSEcCtD
Estropipate—Dyspepsia—Doxorubicin—hematologic cancer	1.07e-05	7.23e-05	CcSEcCtD
Estropipate—Vomiting—Prednisone—hematologic cancer	1.06e-05	7.21e-05	CcSEcCtD
Estropipate—Rash—Prednisone—hematologic cancer	1.06e-05	7.15e-05	CcSEcCtD
Estropipate—Dermatitis—Prednisone—hematologic cancer	1.06e-05	7.14e-05	CcSEcCtD
Estropipate—Headache—Prednisone—hematologic cancer	1.05e-05	7.11e-05	CcSEcCtD
Estropipate—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.05e-05	7.09e-05	CcSEcCtD
Estropipate—Fatigue—Doxorubicin—hematologic cancer	1.05e-05	7.08e-05	CcSEcCtD
Estropipate—Urticaria—Epirubicin—hematologic cancer	1.04e-05	7.05e-05	CcSEcCtD
Estropipate—Pain—Doxorubicin—hematologic cancer	1.04e-05	7.02e-05	CcSEcCtD
Estropipate—Constipation—Doxorubicin—hematologic cancer	1.04e-05	7.02e-05	CcSEcCtD
Estropipate—Abdominal pain—Epirubicin—hematologic cancer	1.04e-05	7.01e-05	CcSEcCtD
Estropipate—Body temperature increased—Epirubicin—hematologic cancer	1.04e-05	7.01e-05	CcSEcCtD
Estropipate—Hypersensitivity—Methotrexate—hematologic cancer	1.03e-05	6.98e-05	CcSEcCtD
Estropipate—Asthenia—Methotrexate—hematologic cancer	1e-05	6.8e-05	CcSEcCtD
Estropipate—Nausea—Prednisone—hematologic cancer	9.95e-06	6.74e-05	CcSEcCtD
Estropipate—Gastrointestinal pain—Doxorubicin—hematologic cancer	9.91e-06	6.71e-05	CcSEcCtD
Estropipate—Pruritus—Methotrexate—hematologic cancer	9.9e-06	6.71e-05	CcSEcCtD
Estropipate—Hypersensitivity—Epirubicin—hematologic cancer	9.65e-06	6.54e-05	CcSEcCtD
Estropipate—Urticaria—Doxorubicin—hematologic cancer	9.63e-06	6.52e-05	CcSEcCtD
Estropipate—Abdominal pain—Doxorubicin—hematologic cancer	9.58e-06	6.49e-05	CcSEcCtD
Estropipate—Body temperature increased—Doxorubicin—hematologic cancer	9.58e-06	6.49e-05	CcSEcCtD
Estropipate—Diarrhoea—Methotrexate—hematologic cancer	9.58e-06	6.49e-05	CcSEcCtD
Estropipate—Asthenia—Epirubicin—hematologic cancer	9.4e-06	6.36e-05	CcSEcCtD
Estropipate—Pruritus—Epirubicin—hematologic cancer	9.27e-06	6.28e-05	CcSEcCtD
Estropipate—Dizziness—Methotrexate—hematologic cancer	9.26e-06	6.27e-05	CcSEcCtD
Estropipate—Diarrhoea—Epirubicin—hematologic cancer	8.96e-06	6.07e-05	CcSEcCtD
Estropipate—Hypersensitivity—Doxorubicin—hematologic cancer	8.93e-06	6.05e-05	CcSEcCtD
Estropipate—Vomiting—Methotrexate—hematologic cancer	8.9e-06	6.03e-05	CcSEcCtD
Estropipate—Rash—Methotrexate—hematologic cancer	8.83e-06	5.98e-05	CcSEcCtD
Estropipate—Dermatitis—Methotrexate—hematologic cancer	8.82e-06	5.97e-05	CcSEcCtD
Estropipate—Headache—Methotrexate—hematologic cancer	8.77e-06	5.94e-05	CcSEcCtD
Estropipate—Asthenia—Doxorubicin—hematologic cancer	8.7e-06	5.89e-05	CcSEcCtD
Estropipate—Dizziness—Epirubicin—hematologic cancer	8.66e-06	5.87e-05	CcSEcCtD
Estropipate—Pruritus—Doxorubicin—hematologic cancer	8.58e-06	5.81e-05	CcSEcCtD
Estropipate—Vomiting—Epirubicin—hematologic cancer	8.33e-06	5.64e-05	CcSEcCtD
Estropipate—Nausea—Methotrexate—hematologic cancer	8.31e-06	5.63e-05	CcSEcCtD
Estropipate—Diarrhoea—Doxorubicin—hematologic cancer	8.29e-06	5.62e-05	CcSEcCtD
Estropipate—Rash—Epirubicin—hematologic cancer	8.26e-06	5.59e-05	CcSEcCtD
Estropipate—Dermatitis—Epirubicin—hematologic cancer	8.25e-06	5.59e-05	CcSEcCtD
Estropipate—Headache—Epirubicin—hematologic cancer	8.21e-06	5.56e-05	CcSEcCtD
Estropipate—Dizziness—Doxorubicin—hematologic cancer	8.02e-06	5.43e-05	CcSEcCtD
Estropipate—Nausea—Epirubicin—hematologic cancer	7.78e-06	5.27e-05	CcSEcCtD
Estropipate—Vomiting—Doxorubicin—hematologic cancer	7.71e-06	5.22e-05	CcSEcCtD
Estropipate—Rash—Doxorubicin—hematologic cancer	7.64e-06	5.18e-05	CcSEcCtD
Estropipate—Dermatitis—Doxorubicin—hematologic cancer	7.64e-06	5.17e-05	CcSEcCtD
Estropipate—Headache—Doxorubicin—hematologic cancer	7.59e-06	5.14e-05	CcSEcCtD
Estropipate—Nausea—Doxorubicin—hematologic cancer	7.2e-06	4.88e-05	CcSEcCtD
Estropipate—ESR1—Signaling Pathways—KITLG—hematologic cancer	4.02e-06	7.22e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NCOR2—hematologic cancer	4.01e-06	7.21e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—GSTM1—hematologic cancer	3.98e-06	7.16e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—NCOR1—hematologic cancer	3.98e-06	7.16e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—JAK2—hematologic cancer	3.94e-06	7.08e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ALOX5—hematologic cancer	3.94e-06	7.08e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—STAT5A—hematologic cancer	3.93e-06	7.06e-05	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.92e-06	7.04e-05	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—CREBBP—hematologic cancer	3.91e-06	7.03e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.91e-06	7.02e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CDKN2B—hematologic cancer	3.89e-06	7e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—IDH1—hematologic cancer	3.82e-06	6.86e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NUP98—hematologic cancer	3.81e-06	6.86e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ABCC3—hematologic cancer	3.78e-06	6.79e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTO1—hematologic cancer	3.78e-06	6.79e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—TXN—hematologic cancer	3.78e-06	6.79e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CD86—hematologic cancer	3.76e-06	6.77e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PIK3CB—hematologic cancer	3.74e-06	6.73e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HES1—hematologic cancer	3.71e-06	6.67e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ADCY7—hematologic cancer	3.7e-06	6.66e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NCOA3—hematologic cancer	3.7e-06	6.66e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—SPHK1—hematologic cancer	3.69e-06	6.64e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NCOR1—hematologic cancer	3.69e-06	6.64e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.69e-06	6.63e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—FHL2—hematologic cancer	3.69e-06	6.63e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NUP214—hematologic cancer	3.68e-06	6.61e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CSF2—hematologic cancer	3.65e-06	6.56e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—FGF1—hematologic cancer	3.65e-06	6.56e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.64e-06	6.54e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—AGRN—hematologic cancer	3.61e-06	6.5e-05	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	3.61e-06	6.5e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—MTR—hematologic cancer	3.6e-06	6.47e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ABCG2—hematologic cancer	3.6e-06	6.47e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—FOXO1—hematologic cancer	3.6e-06	6.47e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PDGFRB—hematologic cancer	3.59e-06	6.46e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—UGT1A1—hematologic cancer	3.55e-06	6.38e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PDGFRA—hematologic cancer	3.53e-06	6.36e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ENO2—hematologic cancer	3.53e-06	6.35e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PRKCG—hematologic cancer	3.52e-06	6.33e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—JAK1—hematologic cancer	3.52e-06	6.33e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—MTHFR—hematologic cancer	3.52e-06	6.33e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—NQO1—hematologic cancer	3.48e-06	6.25e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—CD44—hematologic cancer	3.48e-06	6.25e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CRABP1—hematologic cancer	3.45e-06	6.21e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—SLC22A1—hematologic cancer	3.45e-06	6.21e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IL2—hematologic cancer	3.44e-06	6.18e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—IDH2—hematologic cancer	3.43e-06	6.16e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—HMMR—hematologic cancer	3.43e-06	6.16e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTT1—hematologic cancer	3.43e-06	6.16e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.41e-06	6.12e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.37e-06	6.06e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ALOX5—hematologic cancer	3.36e-06	6.05e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—SDC1—hematologic cancer	3.35e-06	6.02e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—CYCS—hematologic cancer	3.29e-06	5.92e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL2RA—hematologic cancer	3.29e-06	5.91e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—HSP90AA1—hematologic cancer	3.27e-06	5.88e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NUP98—hematologic cancer	3.26e-06	5.86e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TERT—hematologic cancer	3.25e-06	5.85e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.22e-06	5.79e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.2e-06	5.75e-05	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—AKT1—hematologic cancer	3.19e-06	5.74e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PDGFB—hematologic cancer	3.18e-06	5.71e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ADCY7—hematologic cancer	3.16e-06	5.69e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NCOA3—hematologic cancer	3.16e-06	5.69e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.16e-06	5.68e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NUP214—hematologic cancer	3.14e-06	5.65e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CA9—hematologic cancer	3.13e-06	5.63e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ACP5—hematologic cancer	3.13e-06	5.63e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.11e-06	5.59e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TSC2—hematologic cancer	3.1e-06	5.58e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.09e-06	5.56e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—EP300—hematologic cancer	3.08e-06	5.54e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—MTR—hematologic cancer	3.08e-06	5.53e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ABCG2—hematologic cancer	3.08e-06	5.53e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.02e-06	5.43e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ENO2—hematologic cancer	3.02e-06	5.43e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—SRC—hematologic cancer	3e-06	5.39e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—FGFR3—hematologic cancer	2.99e-06	5.37e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CG—hematologic cancer	2.96e-06	5.32e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MAPK14—hematologic cancer	2.96e-06	5.31e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—IDH1—hematologic cancer	2.95e-06	5.3e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.94e-06	5.29e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTT1—hematologic cancer	2.93e-06	5.26e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—VEGFA—hematologic cancer	2.92e-06	5.25e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—TXN—hematologic cancer	2.91e-06	5.24e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.91e-06	5.24e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.91e-06	5.24e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTP1—hematologic cancer	2.9e-06	5.22e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—NRAS—hematologic cancer	2.88e-06	5.18e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.88e-06	5.18e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—FN1—hematologic cancer	2.86e-06	5.15e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—SDC1—hematologic cancer	2.86e-06	5.14e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.85e-06	5.13e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CD44—hematologic cancer	2.85e-06	5.12e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NQO1—hematologic cancer	2.85e-06	5.12e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—BAD—hematologic cancer	2.83e-06	5.09e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NFKBIA—hematologic cancer	2.83e-06	5.09e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.81e-06	5.05e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NOTCH1—hematologic cancer	2.8e-06	5.04e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.79e-06	5.01e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—MAPK3—hematologic cancer	2.76e-06	4.97e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—ABCB1—hematologic cancer	2.75e-06	4.94e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CD80—hematologic cancer	2.75e-06	4.94e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CREBBP—hematologic cancer	2.74e-06	4.93e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KIT—hematologic cancer	2.74e-06	4.93e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CG—hematologic cancer	2.74e-06	4.93e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.74e-06	4.92e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.73e-06	4.91e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.7e-06	4.85e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CYCS—hematologic cancer	2.69e-06	4.84e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PTPN11—hematologic cancer	2.69e-06	4.84e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TGFB1—hematologic cancer	2.68e-06	4.82e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	2.68e-06	4.81e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—GSTM1—hematologic cancer	2.67e-06	4.79e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—NCOR1—hematologic cancer	2.67e-06	4.79e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.66e-06	4.79e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.66e-06	4.79e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CREB1—hematologic cancer	2.61e-06	4.69e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CD—hematologic cancer	2.6e-06	4.68e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.6e-06	4.67e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.58e-06	4.64e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—BRAF—hematologic cancer	2.58e-06	4.63e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—ALB—hematologic cancer	2.57e-06	4.62e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCL2—hematologic cancer	2.55e-06	4.59e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL6R—hematologic cancer	2.54e-06	4.58e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CREBBP—hematologic cancer	2.54e-06	4.57e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NUP98—hematologic cancer	2.51e-06	4.52e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—KRAS—hematologic cancer	2.48e-06	4.46e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3R1—hematologic cancer	2.46e-06	4.42e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.44e-06	4.39e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.44e-06	4.39e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NQO1—hematologic cancer	2.43e-06	4.37e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CD44—hematologic cancer	2.43e-06	4.37e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MAP2K1—hematologic cancer	2.43e-06	4.36e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NUP214—hematologic cancer	2.42e-06	4.36e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CD—hematologic cancer	2.41e-06	4.33e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.41e-06	4.33e-05	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—MAPK3—hematologic cancer	2.38e-06	4.29e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.38e-06	4.28e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.38e-06	4.27e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—MTR—hematologic cancer	2.38e-06	4.27e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.37e-06	4.27e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—MTHFR—hematologic cancer	2.36e-06	4.24e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ENO2—hematologic cancer	2.33e-06	4.19e-05	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—MYC—hematologic cancer	2.32e-06	4.17e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—FGF2—hematologic cancer	2.31e-06	4.15e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CYCS—hematologic cancer	2.3e-06	4.14e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.3e-06	4.13e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.29e-06	4.11e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PIK3CA—hematologic cancer	2.28e-06	4.1e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3R1—hematologic cancer	2.28e-06	4.09e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CB—hematologic cancer	2.27e-06	4.08e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.26e-06	4.06e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.25e-06	4.04e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—JAK2—hematologic cancer	2.21e-06	3.98e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SDC1—hematologic cancer	2.21e-06	3.97e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TP53—hematologic cancer	2.21e-06	3.97e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.18e-06	3.92e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.18e-06	3.92e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MDM2—hematologic cancer	2.16e-06	3.88e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—HRAS—hematologic cancer	2.11e-06	3.79e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MTOR—hematologic cancer	2.1e-06	3.78e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CB—hematologic cancer	2.1e-06	3.78e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.08e-06	3.73e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.06e-06	3.7e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.03e-06	3.65e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CG—hematologic cancer	1.98e-06	3.56e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CDKN1B—hematologic cancer	1.97e-06	3.54e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.96e-06	3.53e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTEN—hematologic cancer	1.96e-06	3.52e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CASP3—hematologic cancer	1.93e-06	3.47e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL2—hematologic cancer	1.93e-06	3.47e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—MTHFR—hematologic cancer	1.93e-06	3.47e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ABCB1—hematologic cancer	1.92e-06	3.45e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCND1—hematologic cancer	1.88e-06	3.38e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CD44—hematologic cancer	1.88e-06	3.38e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NQO1—hematologic cancer	1.88e-06	3.38e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—JUN—hematologic cancer	1.88e-06	3.37e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—EP300—hematologic cancer	1.87e-06	3.36e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.86e-06	3.35e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.86e-06	3.35e-05	CbGpPWpGaD
Estropipate—ALB—Hemostasis—AKT1—hematologic cancer	1.86e-06	3.35e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—CREBBP—hematologic cancer	1.84e-06	3.3e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CDKN1A—hematologic cancer	1.82e-06	3.27e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PTEN—hematologic cancer	1.81e-06	3.26e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CYCS—hematologic cancer	1.78e-06	3.19e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MAPK8—hematologic cancer	1.78e-06	3.19e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.77e-06	3.17e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CD—hematologic cancer	1.74e-06	3.13e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—EP300—hematologic cancer	1.73e-06	3.11e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.7e-06	3.06e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SRC—hematologic cancer	1.68e-06	3.03e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.65e-06	2.96e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3R1—hematologic cancer	1.64e-06	2.95e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—VEGFA—hematologic cancer	1.64e-06	2.95e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—STAT3—hematologic cancer	1.62e-06	2.92e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.62e-06	2.91e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NRAS—hematologic cancer	1.62e-06	2.91e-05	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—AKT1—hematologic cancer	1.61e-06	2.89e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.57e-06	2.82e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MAPK3—hematologic cancer	1.55e-06	2.79e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CB—hematologic cancer	1.52e-06	2.73e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MYC—hematologic cancer	1.51e-06	2.71e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TGFB1—hematologic cancer	1.5e-06	2.7e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.5e-06	2.7e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.48e-06	2.66e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.45e-06	2.61e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.44e-06	2.59e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.44e-06	2.59e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.42e-06	2.56e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—ALB—hematologic cancer	1.41e-06	2.53e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KRAS—hematologic cancer	1.39e-06	2.51e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.38e-06	2.49e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PIK3CA—hematologic cancer	1.38e-06	2.48e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.34e-06	2.42e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTEN—hematologic cancer	1.31e-06	2.36e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.28e-06	2.31e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PIK3CA—hematologic cancer	1.28e-06	2.3e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.27e-06	2.29e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—EP300—hematologic cancer	1.25e-06	2.25e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.24e-06	2.23e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TP53—hematologic cancer	1.24e-06	2.23e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.22e-06	2.19e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—ALB—hematologic cancer	1.2e-06	2.16e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HRAS—hematologic cancer	1.18e-06	2.13e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.15e-06	2.07e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—IL6—hematologic cancer	1.13e-06	2.04e-05	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—AKT1—hematologic cancer	1.13e-06	2.03e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTEN—hematologic cancer	1.07e-06	1.93e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.07e-06	1.92e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.06e-06	1.91e-05	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—AKT1—hematologic cancer	1.05e-06	1.88e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—EP300—hematologic cancer	1.02e-06	1.84e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CREBBP—hematologic cancer	9.91e-07	1.78e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CD—hematologic cancer	9.39e-07	1.69e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—ALB—hematologic cancer	9.27e-07	1.67e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—PIK3CA—hematologic cancer	9.25e-07	1.66e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTEN—hematologic cancer	9.17e-07	1.65e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3R1—hematologic cancer	8.87e-07	1.59e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—EP300—hematologic cancer	8.74e-07	1.57e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CB—hematologic cancer	8.19e-07	1.47e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PIK3CA—hematologic cancer	7.57e-07	1.36e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—AKT1—hematologic cancer	7.55e-07	1.36e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTEN—hematologic cancer	7.07e-07	1.27e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—EP300—hematologic cancer	6.75e-07	1.21e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PIK3CA—hematologic cancer	6.47e-07	1.16e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—AKT1—hematologic cancer	6.18e-07	1.11e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—AKT1—hematologic cancer	5.28e-07	9.5e-06	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.99e-07	8.97e-06	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—AKT1—hematologic cancer	4.08e-07	7.33e-06	CbGpPWpGaD
